Healthcare reality of the treatment of the high-risk multiple myeloma in Spain

被引：2
|
作者：
Hernandez-Rivas, Jose-Angel [1 ,2 ]
Gironella Mesa, Mercedes [3 ,4 ]
机构：
[1] Hosp Univ Infanta Leonor, Serv Hematol & Hemoterapia, Madrid, Spain
[2] Univ Complutense Madrid, Dept Med, Madrid, Spain
[3] Hosp Univ Vail dHebron, Serv Hematol, Barcelona, Spain
[4] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain
来源：
MEDICINA CLINICA | 2020年 / 154卷 / 08期
关键词：
LENALIDOMIDE PLUS DEXAMETHASONE; TREATMENT STRATEGIES; CONSENSUS; STRATIFICATION; CARFILZOMIB; GUIDELINES; MANAGEMENT; SURVIVAL;
D O I：
10.1016/j.medcli.2019.10.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：315 / 319
页数：5
相关论文
共 50 条
  • [41] High-risk multiple myeloma: a multifaceted entity, multiple therapeutic challenges
    Muchtar, Eli
    Magen, Hila
    Gertz, Morie A.
    LEUKEMIA & LYMPHOMA, 2017, 58 (06) : 1283 - 1296
  • [42] Early Therapy Benefits High-Risk Smoldering Multiple Myeloma
    不详
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (11) : E1 - E1
  • [43] Clinicopathological Characteristics of Hyperdiploidy with High-Risk Cytogenetics in Multiple Myeloma
    Yang, Naery
    Mun, Yeung Chul
    Seong, Chu-Myong
    Huh, Hee Jin
    Huh, Jungwon
    ANNALS OF LABORATORY MEDICINE, 2018, 38 (02) : 160 - +
  • [44] Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma
    J R Sawyer
    E Tian
    J D Shaughnessy Jr
    J Epstein
    C M Swanson
    C Stangeby
    C L Hale
    L Parr
    M Lynn
    G Sammartino
    J L Lukacs
    C Stein
    C Bailey
    M Zangari
    F E Davies
    F Van Rhee
    B Barlogie
    G J Morgan
    Leukemia, 2017, 31 : 637 - 644
  • [45] Genomic characterization of functional high-risk multiple myeloma patients
    Soekojo, Cinnie Yentia
    Chung, Tae-Hoon
    Furqan, Muhammad Shaheryar
    Chng, Wee Joo
    BLOOD CANCER JOURNAL, 2022, 12 (01)
  • [46] Myc rearrangement redefines the stratification of high-risk multiple myeloma
    Jin, Xianghong
    Li, Hui
    Zhang, Dingding
    Liu, Shuangjiao
    Song, Yuhang
    Zhang, Fujing
    Li, Ziping
    Zhuang, Junling
    CANCER MEDICINE, 2024, 13 (11):
  • [47] Erratum: A gene expression signature for high-risk multiple myeloma
    R Kuiper
    A Broyl
    Y de Knegt
    M H van Vliet
    E H van Beers
    B van der Holt
    L el Jarari
    G Mulligan
    W Gregory
    G Morgan
    H Goldschmidt
    H M Lokhorst
    M van Duin
    P Sonneveld
    Leukemia, 2014, 28 : 1178 - 1180
  • [48] Genomic profiling of treated high-risk smoldering multiple myeloma
    Diamond, Benjamin
    Kazandjian, Dickran
    Papadimitriou, Marios
    Ziccheddu, Bachisio
    Blaney, Patrick
    Chojnacka, Monika
    Durante, Michael
    Hill, Elizabeth
    Sklavenitis-Pistofidis, Romanos
    Davies, Faith
    Getz, Gad
    Ghobrial, Irene
    Morgan, Gareth
    Maura, Francesco
    Landgren, Ola
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S227 - S228
  • [49] Evolutionary dynamics and optimal management of high-risk multiple myeloma
    Shain, Kenneth
    Khin, Zayar
    Silva, Ariosto
    CLINICAL CANCER RESEARCH, 2015, 21
  • [50] High-Risk Multiple Myeloma: Different Definitions, Different Outcomes?
    Paszekova, Helena
    Kryukov, Fedor
    Kubiczkova, Lenka
    Hajek, Roman
    Sevcikova, Sabina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (01): : 24 - 30
12345